Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters

Condition:   Venous Thromboembolism Interventions:   Drug: Rivaroxaban;   Drug: Warfarin;   Drug: Nadroparin Sponsors:   Second Affiliated Hospital, School of Medicine, Zhejiang University;   Sir Run Run Shaw Hospital;   Huadong Hospital;   Shanghai Zhongshan Hospital;   Shanghai 5th People's Hospital;   Yantai Yuhuangding Hospital;   Anhui Provincial Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials